Skip to content

Company information lookup

NARHEX LIFE SCIENCES LIMITED (NLS)

Research and commercial development of drugs for the treatment of HIV/AIDS.

On this page you will find:

Company snapshot
Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
NLS 0.006 0% 0.005 0.006 0.006 0.006 0.006 80,000

NARHEX LIFE SCIENCES LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code NLS
Securities
Official Listing Date 12 January, 2005
GICS Industry Group Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign? No
Internet Address http://www.narhex.com.au
Registered Office Address Level 24, 44 St George's Terrace, PERTH, WA, AUSTRALIA, 6000
Head Office Telephone +61 8 6211 5099
Head Office Fax +61 8 9218 8875
Share Registry LINK MARKET SERVICES LIMITED
GROUND FLOOR, 178 ST GEORGES TERRACE, PERTH, WA, AUSTRALIA, 6000
Share Registry Telephone 1300 554 474
Directors / Senior Management
Mr Cyril D'Silva (Executive Chairman, Director)
Mr Robert Ramsay (Non Exec. Director)
Mr Adam Sierakowski (Non Exec. Director)
Company Secretary Ms Nicki Farley
Principal Activities Research and commercial development of drugs for the treatment of HIV/AIDS.

NARHEX LIFE SCIENCES LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
13/03/2014   Change of Director's Interest Notice 2 PDF
04/03/2014   Change of Director's Interest Notice 3 PDF
28/02/2014 asterix Half Yearly Report and Accounts 31 December 2013 18 PDF
14/02/2014 asterix Agreement to Acquire 75% of Guinea Exploration Company 5 PDF
24/01/2014 asterix Appendix 4C - quarterly 5 PDF
27/12/2013   Placement - Section 708A Notice 1 PDF
27/12/2013   Appendix 3B 12 PDF
20/12/2013   Initial Director's Interest Notice 2 PDF
20/12/2013   Final Directors' Interest Notices 6 PDF
20/12/2013 asterix Acquisition of GSAL, Placement & Board Changes 5 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
17 Apr 2014 0.006 0% 0.006 0.006 80,000
31 Mar 2014 0.006 -14.29% 0.006 0.006 800,000
17 Mar 2014 0.007 16.67% 0.007 0.006 2,463,333
07 Mar 2014 0.006 0% 0.006 0.006 100,000
03 Mar 2014 0.006 20% 0.006 0.006 100,000

* Volume of shares shown represents only those shares traded on ASX.

NARHEX LIFE SCIENCES LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security NLS. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security NLS

Warrants & Structured Products

No warrants & Structured Products are available over the security NLS

ASX CFDs

No Contracts For Differences are available over the security NLS